Hikal - Quaterly Results

04 Feb 2025 Evaluate
The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 4477.00 millions.A humble growth in net profit of 6.79% reported in the quarter ended December 2024 to Rs. 173.00  millions from Rs. 162.00 millions.The company reported a good operating profit of 758.00 millions compared to 649.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4477.00 4475.00 0.04 13074.00 12704.00 2.91 17846.00 20230.30 -11.79
Other Income 36.00 1.00 3500.00 45.00 20.00 125.00 24.50 54.10 -54.71
PBIDT 758.00 649.00 16.80 2095.00 1746.00 19.99 2693.90 2624.70 2.64
Interest 187.00 142.00 31.69 573.00 411.00 39.42 563.70 481.00 17.19
PBDT 571.00 507.00 12.62 1522.00 1335.00 14.01 2130.20 2143.70 -0.63
Depreciation 332.00 290.00 14.48 967.00 853.00 13.36 1176.10 1090.10 7.89
PBT 239.00 217.00 10.14 555.00 482.00 15.15 954.10 1053.60 -9.44
TAX 66.00 55.00 20.00 149.00 126.00 18.25 259.00 269.80 -4.00
Deferred Tax 21.00 3.00 600.00 22.00 2.00 1000.00 -24.70 -35.00 -29.43
PAT 173.00 162.00 6.79 406.00 356.00 14.04 695.10 783.80 -11.32
Equity 247.00 247.00 0.00 247.00 247.00 0.00 246.60 246.60 0.00
PBIDTM(%) 16.93 14.50 16.74 16.02 13.74 16.59 15.10 12.97 16.35

Hikal Share Price

400.10 -4.65 (-1.15%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...